Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy (Q42705834)
Jump to navigation
Jump to search
scientific article published on 29 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy |
scientific article published on 29 April 2014 |
Statements
1 reference
Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy (English)
1 reference
Lewis R Silverman
1 reference
Peter Greenberg
1 reference
Azra Raza
1 reference
Matthew J Olnes
1 reference
James F Holland
1 reference
Premkumar Reddy
1 reference
Manoj Maniar
1 reference
Francois Wilhelm
1 reference
29 April 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference